Security key
74017N105
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 62,597,104
- Total 13F value
- $83,879,140
- Share change
- +2,001,146
- Put/Call ratio
- 29%
- SEC-reported price per share
- $1.34
- Number of holders
- 136
- Value change
- +$2,482,228
- Number of buys
- 49
- Number of sells
- 62
- Shares outstanding
- 353,007,843
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2023
Institutions
136
Top holders
10
PGEN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
PRECIGEN, INC. SEC filings
PRECIGEN, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74017N105
Recent filing periods:
Ownership snapshot
Top reported holders of PGEN - PRECIGEN, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Patient Capital Managemen...
Disclosed value leader
Patient Capital Managemen...
Comparable rows
15/15
Latest evidence
30 Sep 2023
13F
Lead comparable stake: 3.9%
Showing 1-6 of 15 holder rows.
Quick read
Patient Capital Management, LLC leads the comparable SEC ownership view at 3.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Patient Capital Management, LLC's linked filing trail.
Comparable ownership
Top 5
Patient Capital Management, LLC
3.9%
BlackRock Finance, Inc.
3%
VANGUARD GROUP INC
2%
GEODE CAPITAL MANAGEMENT, LLC
0.82%
STATE STREET CORP
0.78%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Patient Capital Management, LLC |
13F
Company
|
3.9%
|
$19,529,510
13,753,176 shares
|
— | 30 Sep 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
3%
|
$14,847,887
10,456,258 shares
|
— | 30 Sep 2023 |
| VANGUARD GROUP INC |
13F
Company
|
2%
|
$9,870,241
6,950,874 shares
|
— | 30 Sep 2023 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.82%
|
$4,134,473
2,911,255 shares
|
— | 30 Sep 2023 |
| STATE STREET CORP |
13F
Company
|
0.78%
|
$3,928,383
2,766,467 shares
|
— | 30 Sep 2023 |
| IRIDIAN ASSET MANAGEMENT LLC/CT |
13F
Company
|
0.59%
|
$2,951,072
2,078,220 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
136
Shares
62,597,104
Rows available
136
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
135
Q4 2023 holders
136
Holder diff
1
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend